NIOX Group (LON:NIOX) Stock Price Down 0.6% – Here’s Why

NIOX Group Plc (LON:NIOX) dropped 0.6% on Wednesday . The company traded as low as GBX 66.20 and last traded at GBX 67.20. Approximately 604,052 shares traded hands during trading, a decline of 38% from the average daily volume of 967,638 shares. The stock had previously closed at GBX 67.60.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft cut their target price on NIOX Group from GBX 90 to GBX 86 and set a “buy” rating for the company in a research note on Wednesday, January 21st. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of GBX 88.

NIOX Group Stock Performance

The company has a quick ratio of 1.94, a current ratio of 6.31 and a debt-to-equity ratio of 1.10. The company has a fifty day moving average price of GBX 67.65 and a 200 day moving average price of GBX 69.99. The stock has a market cap of £275.24 million, a PE ratio of 52.69 and a beta of 0.92.

Insider Activity at NIOX Group

In other news, insider Sarah Duncan acquired 5,522 shares of the stock in a transaction dated Wednesday, December 3rd. The stock was purchased at an average cost of GBX 71 per share, with a total value of £3,920.62. Company insiders own 4.88% of the company’s stock.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.